EFFECTS OF ORAL LEVOSIMENDAN (ODM-109) ON RESPIRATORY FUNCTION IN PATIENTS WITH ALS: OPEN-LABEL EXTENSION FOR PATIENTS COMPLETING STUDY 3119002
Clinical Trial Grant
Administered By
Neurology
Awarded By
Orion Corporation
Start Date
December 10, 2019
End Date
March 31, 2021
Administered By
Neurology
Awarded By
Orion Corporation
Start Date
December 10, 2019
End Date
March 31, 2021